In breast cancer, Lunasin has been shown to suppress the migration and invasion of breast cancer cells by inhibiting matrix metalloproteinase-2/-9 (MMP-2/-9) via the FAK/Akt/ERK and NF-κB signaling pathways (45). Here, PTK2 is linked to breast carcinoma.